首页> 外文期刊>Cellular and molecular life sciences: CMLS >Unique patterns of CD8+T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease
【24h】

Unique patterns of CD8+T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease

机译:在急性移植物抗宿主病的Act-mOVA / OT-I模型中,CD8 + T细胞介导的器官损伤的独特模式

获取原文
获取原文并翻译 | 示例
       

摘要

T-cell receptor (TCR)-transgenic models of acute graft-versus-host disease (aGvHD) offer a straightforward and highly controlled approach to study the mechanisms and consequences of T-cell activation following allogeneic hematopoietic stem cell transplantation (aHSCT). Here, we report that aHSCT involving OT-I mice as donors, carrying an ovalbumin-specific CD8+ TCR, and Act-mOVA mice as recipients, expressing membrane-bound ovalbumin driven by the beta-actin promoter, induces lethal aGvHD in a CD8+ T-cell-dependent, highly reproducible manner, within 4-7 days. Tracking of UBC-GFP/OT-I graft CD8+ T cells disclosed heavy infiltration of the gastrointestinal tract, liver, and lungs at the onset of the disease, and histology confirmed hallmark features of gastrointestinal aGVHD, hepatic aGvHD, and aGvHD-associated lymphocytic bronchitis in infiltrated organs. However, T-cell infiltration was virtually absent in the skin, a key target organ of human aGvHD, and histology confirmed the absence of cutaneous aGVHD, as well. We show that the model allows studying CD8+ T-cell responses in situ, as selective recovery of graft CD45.1/OT-I CD8+ T cells from target organs is simple and feasible by automated tissue dissociation and subsequent cell sorting. Assessment of interferon-gamma production by flow cytometry, granzyme-B release by ELISA, TREC assay, and whole-genome gene expression profiling confirmed that isolated graft CD8+ T cells remained intact, underwent clonal expansion, and exerted effector functions in all affected tissues. Taken together, these data demonstrate that the OT-I/Act-mOVA model is suitable to study the CD8+ T-cell-mediated effector mechanisms in a disease closely resembling fatal human gastrointestinal and hepatic aGVHD that may develop after aHSCT using HLA-matched unrelated donors.
机译:急性移植物抗宿主病(aGvHD)的T细胞受体(TCR)转基因模型为研究同种异体造血干细胞移植(aHSCT)后T细胞活化的机制和后果提供了一种直接且高度受控的方法。在这里,我们报告aHSCT涉及以卵白蛋白特异性CD8 + TCR为宿主的OT-1小鼠作为供体,以受体β-肌动蛋白启动子驱动的膜结合卵白蛋白表达的Act-mOVA小鼠为受体,在CD8 + T中诱导致命的aGvHD。 -细胞依赖性,高度可重复的方式,在4-7天内。对UBC-GFP / OT-1移植CD8 + T细胞的追踪揭示了该病发作时胃肠道,肝和肺的大量浸润,并且组织学证实了胃肠道aGVHD,肝脏aGvHD和与aGvHD相关的淋巴细胞性支气管炎的标志性特征在浸润的器官中。但是,人类aGvHD的关键靶器官皮肤中几乎没有T细胞浸润,并且组织学也证实了皮肤aGVHD的缺失。我们显示该模型允许原位研究CD8 + T细胞反应,因为通过自动组织解离和随后的细胞分选从目标器官中选择性回收移植CD45.1 / OT-1 CD8 + T细胞是简单可行的。通过流式细胞术评估γ-干扰素的产生,通过ELISA,TREC分析和全基因组基因表达谱分析法测定颗粒酶B的释放,证实分离的移植CD8 + T细胞保持完整,进行了克隆扩增并在所有受影响的组织中发挥了效应子功能。综上所述,这些数据表明,OT-I / Act-mOVA模型适用于研究CD8 + T细胞介导的效应器机制,该疾病与致命的人类胃肠道和肝脏aGVHD非常相似,该疾病在使用HLA匹配的非相关性aHSCT后可能发展捐助者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号